Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 8 Breast Neoplasms 6 Prostatic Neoplasms 4 Lung Neoplasms 4 Stomach Neoplasms 3 Agnosia 3 Pain 2 Neoplasms 2 Meningioma 2 Colorectal Neoplasms 2 Supratentorial Neoplasms 1 Postoperative Complications 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Pain, Intractable 1 Oropharyngeal Neoplasms 1 Neuroblastoma 1 Neoplasm Metastasis 1 Liver Neoplasms 1 Liver Diseases 1 Kidney Neoplasms 1 Ganglion Cysts 1 Esophageal Neoplasms 1 Emergence Delirium 1 ENT Cancers 1 Cystic Adenomatoid Malformation of Lung, Congenital 1 Colonic Neoplasms 1 Carpal Tunnel Syndrome 1 Cancer Pain 1 Bronchopulmonary Sequestration 1

Interventions

pyrotinib 1 Ropivacaine 1 Radiosurgery 1 Propofol 1 Ondansetron 1 Morphine 1 Etoricoxib 1 Docetaxel 1 Diagnostic Imaging 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Breast Neoplasm Female × Ropivacaine × Clear all

NCT03117894 2021-06-04

PECS-2 for Breast Surgery

Umeå University

Phase NA Completed

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡